Replies to Post #205771 onBiotech Values | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Replies to post #205771 on Biotech Values

Replies to #205771 on Biotech Values

11/17/16 11:09 AM

#206160 RE: DewDiligence #205771

MNTA’s CEO says M230 is the most exciting compound in the company’s pipeline; this PR explains what it is:

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-publication-design-130000320.html

11/26/16 12:29 PM

#206367 RE: DewDiligence #205771

MNTA—Index re potential competition for generic Copaxone:

#msg-126811385